JT
John T. Treace bought $341K of TMCI stock
John T. Treace, Chief Executive Officer, 10% of Treace Medical Concepts, Inc. (TMCI), bought 115,520 shares of TMCI stock worth $341K, per an SEC Form 4 filed May 28, 2026.
It was an open-market purchase.
The trade happened on May 26, 2026, 2 days before it was made public.
TMCI has moved +52.3% since the trade date, from $2.83 to $4.31 (Nov 20, 2026 close).
- Traded
- May 26, 2026
- Disclosed
- May 28, 2026
- Filing delay
- 2 days
- Price since
- +52.3%
- Role
- Chief Executive Officer, 10%
- Source
- SEC Form 4